Non-cholesterol sterols in different forms of primary hyperlipemias

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 22, Issue 3, 2012, Pages 231-236

  Lupattelli, G ^a   Pirro, M ^a   Siepi, D ^a   Mannarino, M R ^a   Roscini, A R ^a   Vaudo, G ^a   Pasqualini, L ^a   Schillaci, G ^a   Mannarino, E ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Familial combined hyperlipemia; Non cholesterol sterols; Polygenic hypercholesterolemia

Indexed keywords

BIOLOGICAL MARKER; CAMPESTEROL; CHOLESTEROL; DRUG DERIVATIVE; LATHOSTEROL; PHYTOSTEROL; SITOSTEROL; SITOSTEROL DERIVATIVE; STEROL;

ADULT; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; FAMILIAL HYPERLIPEMIA; FEMALE; GENETICS; HUMAN; HYPERCHOLESTEROLEMIA; INTESTINE ABSORPTION; ITALY; MALE; MASS FRAGMENTOGRAPHY; MIDDLE AGED; MULTIFACTORIAL INHERITANCE; MULTIVARIATE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOLESTEROL; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA, FAMILIAL COMBINED; INTESTINAL ABSORPTION; ITALY; LINEAR MODELS; MALE; MIDDLE AGED; MULTIFACTORIAL INHERITANCE; MULTIVARIATE ANALYSIS; PHYTOSTEROLS; RISK ASSESSMENT; RISK FACTORS; SITOSTEROLS; STEROLS; YOUNG ADULT;

EID: 84857912289     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2010.05.010     Document Type: Article

References (33)

1. Bosner M.S., Lange L.G., Stenson W.F., Ostlund R.E. Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry. J Lipid Res 1999, 40:302-308.
2. Miettinen T.A., Strandberg T.E., Gylling H. Arterioscler Thromb Vasc Biol 2000, 20:1340-1346. for the Finnish Investigators of the Scandinavian Simvastatin Survival Study Group.
3. Gylling H., Miettinen T.A. Inheritance of cholesterol metabolism of probands with high or low cholesterol absorption. J Lipid Res 2002, 43:1472-1476.
4. Berge K.E., von Bergmann K., Lutjohann D., Guerra R., Grundy S.M., Hobbs H.H., et al. Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J Lipid Res 2002, 43:486-494.
5. Kesaniemi Y.A., Miettinen T.A. Cholesterol absorption efficiency regulates plasma cholesterol level in the Finnish population. Eur J Clin Invest 1987, 17:391-395.
6. Miettinen T.A., Tilvis R.S., Kesaniemi Y.A. Serum plant sterols and cholesterol precursors reflect absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 1990, 131:20-31.
7. Strandberg T.E., Salomaa V., Vanhanen H., Miettinen T.A. Associations of fasting blood glucose with cholesterol absorption and synthesis in non diabetic middLe aged men. Diabetes 1996, 45:755-761.
8. Pihlajamaki J., Gylling H., Miettinen T.A., Laakso M. Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men. J Lipid Res 2004, 45:507-512.
9. Miettinen T.A., Gylling H. Blood glucose and the metabolism of cholesterol in coronary patients with and without simvastatin treatment. Clin Chim Acta 2007, 379:53-58. Subgroup analysis of Scandinavian Simvastatin Survival Study.
10. Hu F.B., Stampfer M.J., Rimm E.B., Manson J.E., Ascherio A., Colditz G.A., et al. A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA 1999, 281:1387-1394.
11. Durrington P. Dyslipidemia. Lancet 2003, 362:717-731.
12. Hopkins P.N., Heiss G., Ellison R.C., Province M.A., Pankow J.S., Eckfeldt J.H., et al. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study. Circulation 2003, 108:519-523.
13. Genest J.J., Martin-Munley S.S., McNamara J.R., Ordovas J.M., Jenner J., Myers R.H., et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 1992, 85:2025-2033.
14. Garcìa-Otin A.L., Cofàn M., Junyent M., Recalde D., Cenarro A., Pocovì M., et al. Increased intestinal cholesterol absorption in autosomal dominant hypercholesterolemia and no mutations in the low-density lipoprotein receptor or apolipoprotein B genes. J Clin Endocrinol Metab 2007, 92:3667-3673.
15. van Himbergen T.M., Otokozawa S., Matthan N.R., Schaefer E.J., Buchsbaum A., Ai M., et al. Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway. Arterioscler Thromb Vasc Biol 2010, 30:113-120.
16. Ahmida H.S.M., Bertucci P., Franzò L., Massoud R., Cortese C., Lala A., et al. Simultaneous determination of plasmatic phytosterols and cholesterol precursors using gas chromatography-mass spectrometry (GC-MS) with selective ion monitoring (SIM). J Chromatogr B 2006, 842:43-47.
17. Simonen P., Gylling H., Howard A.N., Miettinen T.A. Introducing a new component of the metabolic syndrome: low cholesterol absorption. Am J Clin Nutr 2000, 72:82-88.
18. Knopp R.H., Retzlaff B., Fish B., Walden C., Wallick S., Anderson M., et al. Effects of insulin resistance and obesity on lipoproteins and sensitivity to egg feeding. Arterioscler Thromb Vasc Biol 2003, 23:1437-1443.
19. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Executive summary of the Third Report of the National cholesterol Education Program (NCEP). JAMA 2001, 285:2486-2497.
20. Carr M.C., Brunzell J.D. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab 2004, 89:2601-2607.
21. Peltola P., Pihlajamäki J., Koutnikova H., Ruotsalainen E., Salmenniemi U., Vauhkonen I., et al. Visceral obesity is associated with high levels of serum squalene. Obesity 2006, 14:1155-1163.
22. Tobin K.A., Ulven S.M., Schuster G.U., Steineger H.H., Andresen S.M., Gustafsson J.A., et al. Liver X receptors as insulin-mediating factors in fatty acid and cholesterol biosynthesis. J Biol Chem 2002, 277:10691-10697.
23. Yu L., York J., von Bergmann K., Lutjohann D., Cohen J.C., Hobbs H.H. Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8. J Biol Chem 2003, 278:15565-15570.
24. Berge K.E., Tian H., Graf G.A., Yu L., Grishin N.V., Schultz J., et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000, 290:1771-1775.
25. Mannarino E., Pirro M., Cortese C., Lupattelli G., Siepi D., Mezzetti A., et al. Effects of a phytosterol-enriched dairy product on lipids, sterols and 8-isoprostane in hypercholesterolemic patients: a multicenter Italian study. Nutr Metab Cardiovasc Dis 2009, 19:84-90.
26. Cohen J.C., Pertsemlidis A., Fahmi S., Esmail S., Vega G.L., Grundy S.M., et al. Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. Proc Natl Acad Sci U S A 2006, 103:1810-1815.
27. Hubácek J.A., Berge K.E., Stefková J., Pitha J., Skodová Z., Lánská V., et al. Polymorphisms in ABCG5 and ABCG8 transporters and plasma cholesterol levels. Physiol Res 2004, 53:395-401.
28. Kesaniemi Y.A., Ehnholm C., Miettinen T.A. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. Eur J Clin Invest 1987, 80:578-581.
29. Dreon D.M., Femstrom H.A., Miller B., Krauss R.M. Apolipoprotein E isoform phenotype and LDL subclass response to a reduced fat diet. Arterioscler Thromb Vasc Biol 1995, 15:105-111.
30. Martin L.J., Connelly P.W., Nancoo D., Wood N., Zhang Z.J., Maguire G., et al. Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E genotype. J Lipid Res 1993, 34:437-446.
31. Von Bergmann K., Lütjohann D., Lindenthal B., Steinmetz A. Efficiency of intestinal cholesterol absorption in humans is not related to apo E phenotype. J Lipid Res 2003, 44:193-197.
32. Ginsberg H.N., Kris-Etherton P., Dennis B., Elmer P.J., Ershow A., Lefevre M., et al. Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1. Arterioscler Thromb Vasc Biol 1998, 18:441-449.
33. Hayek T., Ito Y., Azrolan N., Verdery R.B., Aalto-Setala K., Walsh A., Breslow J.L. Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (apo) A-I. J Clin Invest 1993, 91:1665-1671.